Mittal D - Search Results

1

CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.

Turcotte M, Allard D, Mittal D, Bareche Y, Buisseret L, José V, Pommey S, Delisle V, Loi S, Joensuu H, Kellokumpu-Lehtinen PL, Sotiriou C, Smyth MJ, Stagg J. Turcotte M, et al. Among authors: mittal d. Cancer Res. 2017 Oct 15;77(20):5652-5663. doi: 10.1158/0008-5472.CAN-17-0707. Epub 2017 Aug 30. Cancer Res. 2017. PMID: 28855210

2

Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor.

Mittal D, Young A, Stannard K, Yong M, Teng MW, Allard B, Stagg J, Smyth MJ. Mittal D, et al. Cancer Res. 2014 Jul 15;74(14):3652-8. doi: 10.1158/0008-5472.CAN-14-0957. Epub 2014 Jul 1. Cancer Res. 2014. PMID: 24986517 Free article.

3

Targeting cancer-derived adenosine: new therapeutic approaches.

Young A, Mittal D, Stagg J, Smyth MJ. Young A, et al. Among authors: mittal d. Cancer Discov. 2014 Aug;4(8):879-88. doi: 10.1158/2159-8290.CD-14-0341. Epub 2014 Jul 17. Cancer Discov. 2014. PMID: 25035124 Review.

4

Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells.

Mittal D, Caramia F, Michiels S, Joensuu H, Kellokumpu-Lehtinen PL, Sotiriou C, Loi S, Smyth MJ. Mittal D, et al. Cancer Res. 2016 Jan 15;76(2):264-74. doi: 10.1158/0008-5472.CAN-15-1567. Epub 2016 Jan 7. Cancer Res. 2016. PMID: 26744522

5

Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis.

Mittal D, Sinha D, Barkauskas D, Young A, Kalimutho M, Stannard K, Caramia F, Haibe-Kains B, Stagg J, Khanna KK, Loi S, Smyth MJ. Mittal D, et al. Cancer Res. 2016 Aug 1;76(15):4372-82. doi: 10.1158/0008-5472.CAN-16-0544. Epub 2016 May 24. Cancer Res. 2016. PMID: 27221704

6

CD96 Is an Immune Checkpoint That Regulates CD8⁺ T-cell Antitumor Function.

Mittal D, Lepletier A, Madore J, Aguilera AR, Stannard K, Blake SJ, Whitehall VLJ, Liu C, Bettington ML, Takeda K, Long GV, Scolyer RA, Lan R, Siemers N, Korman A, Teng MWL, Johnston RJ, Dougall WC, Smyth MJ. Mittal D, et al. Cancer Immunol Res. 2019 Apr;7(4):559-571. doi: 10.1158/2326-6066.CIR-18-0637. Epub 2019 Mar 20. Cancer Immunol Res. 2019. PMID: 30894377 Free PMC article.

7

Interleukin-12 from CD103⁺ Batf3-Dependent Dendritic Cells Required for NK-Cell Suppression of Metastasis.

Mittal D, Vijayan D, Putz EM, Aguilera AR, Markey KA, Straube J, Kazakoff S, Nutt SL, Takeda K, Hill GR, Waddell N, Smyth MJ. Mittal D, et al. Cancer Immunol Res. 2017 Dec;5(12):1098-1108. doi: 10.1158/2326-6066.CIR-17-0341. Epub 2017 Oct 25. Cancer Immunol Res. 2017. PMID: 29070650

8

Overcoming Acquired PD-1/PD-L1 Resistance with CD38 Blockade.

Mittal D, Vijayan D, Smyth MJ. Mittal D, et al. Cancer Discov. 2018 Sep;8(9):1066-1068. doi: 10.1158/2159-8290.CD-18-0798. Cancer Discov. 2018. PMID: 30181171

9

Blockade of ErbB2 and PD-L1 using a bispecific antibody to improve targeted anti-ErbB2 therapy.

Mittal D, Vijayan D, Neijssen J, Kreijtz J, Habraken MMJM, Van Eenennaam H, Van Elsas A, Smyth MJ. Mittal D, et al. Oncoimmunology. 2019 Aug 26;8(11):e1648171. doi: 10.1080/2162402X.2019.1648171. eCollection 2019. Oncoimmunology. 2019. PMID: 31646095 Free PMC article.

10

New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape.

Mittal D, Gubin MM, Schreiber RD, Smyth MJ. Mittal D, et al. Curr Opin Immunol. 2014 Apr;27:16-25. doi: 10.1016/j.coi.2014.01.004. Epub 2014 Feb 14. Curr Opin Immunol. 2014. PMID: 24531241 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters